CG
GBT

Cutler Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Cutler Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-800
Closed -$54K – 5663
2022
Q3 		$54K Sell
800
-442
-36% -$24.4K ﹤0.01% 1844
2022
Q2 		$39K Sell
1,242
-16,295
-93% -$477K ﹤0.01% 2143
2022
Q1 		$607K Buy
17,537
+17,337
+8,669% +$518K 0.03% 604
2021
Q4 		$5K Sell
200
-1,000
-83% -$31K ﹤0.01% 4270
2021
Q3 		$30K Buy
1,200
+55
+5% +$1.62K ﹤0.01% 2982
2021
Q2 		$40K Sell
1,145
-1,555
-58% -$60.7K ﹤0.01% 2694
2021
Q1 		$110K Sell
2,700
-2,215
-45% -$102K 0.01% 1704
2020
Q4 		$212K Buy
4,915
+1,415
+40% +$69.8K 0.01% 1055
2020
Q3 		$192K Buy
+3,500
New +$222K 0.01% 932
2020
Q1 		– Sell
-800
Closed -$53.6K – 4888
2019
Q4 		$63K Sell
800
-1,300
-62% -$77K ﹤0.01% 1470
2019
Q3 		$101K Sell
2,100
-1,400
-40% -$73K 0.01% 1065
2019
Q2 		$184K Buy
3,500
+2,687
+331% +$154K 0.02% 762
2019
Q1 		$43K Sell
813
-9,440
-92% -$464K ﹤0.01% 1541
2018
Q4 		$420K Sell
10,253
-747
-7% -$28K 0.04% 384
2018
Q3 		$418K Buy
11,000
+3,767
+52% +$167K 0.03% 536
2018
Q2 		$326K Buy
+7,233
New +$329K 0.03% 584
2018
Q1 		– Sell
-26,584
Closed -$1.48M – 5505
2017
Q4 		$1.05M Buy
26,584
+26,257
+8,030% +$981K 0.04% 317
2017
Q3 		$10K Sell
327
-6,534
-95% -$184K ﹤0.01% 3838
2017
Q2 		$187K Sell
6,861
-6,024
-47% -$179K 0.01% 1341
2017
Q1 		$474K Buy
12,885
+11,129
+634% +$280K 0.02% 668
2016
Q4 		$25K Buy
1,756
+356
+25% +$6.25K ﹤0.01% 3248
2016
Q3 		$32K Sell
1,400
-200
-13% -$3.81K ﹤0.01% 2944
2016
Q2 		$26K Sell
1,600
-900
-36% -$18.2K ﹤0.01% 3091
2016
Q1 		$39K Buy
+2,500
New +$44.4K ﹤0.01% 2594

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cutler Group's GBT Position: Q4 2022 in Review

Cutler Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 800 shares — an estimated $54K sold.

Cutler Group first reported a position in GBT in Q1 2016 and held it in 24 quarters. The position peaked at $1.05M in Q4 2017. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Cutler Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 800 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $54K.
  • Cutler Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 24 quarters.
  • Cutler Group's Global Blood Therapeutics, Inc. position peaked at $1.05M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.